Melissa J Call

12PUBLICATIONS
57CO-AUTHORS
Tissue engineeringPharmacogenomicsGenomics and transcriptomicsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 12, 2026
The transmembrane domain structure of TNFR1 suppresses ligand-independent autoactivation but is not required for TNF-induced signaling.

|Sep 05, 2025
Divergent resistance pathways amongst SARS-CoV-2 PLpro inhibitors highlight the need for scaffold diversity.

Xinyu Wu, Shane M Devine, Margareta Go

|Sep 04, 2025
Insights from deep mutational scanning in the context of an emerging pathogen.

Melissa J Call, Matthew E Call, Xinyu Wu

|Apr 03, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.

Stefanie M Bader, Dale J Calleja, Shane M Devine

|Jul 23, 2024
Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape.

Xinyu Wu, Margareta Go, Julie V Nguyen

|Mar 09, 2023
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma.

Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson

Pageof 2

Frequent Collaborators

8 joint publications

Matthew E Call

3 joint publications

Xinyu Wu

2 joint publications

David Komander

2 joint publications

Dale J Calleja